Contact number
+49 89 12712 0Chambers Review
The international law firm McDermott Will & Emery enjoys a solid standing in the mid-cap private equity space. Its team is active on a range of mandates including acquisitions, investments and divestitures, often representing domestic and international private equity funds and investors. Portfolio restructurings and auction processes are equally handled while the firm also assists companies and their shareholders with their sales to investors. Although active across a range of sectors, McDermott Will & Emery is particularly visible in deals concerning the life sciences, healthcare and TMT industries. While the practice has its primary focus on domestic mandates, its international law firm network enables it to also effectively handle cross-border matters.
Work Highlights
- McDermott Will & Emery advised Ampersand Capital Partners on its investment with KKR in the business combination of Biosynth and Vivitide.